[{"country": "United States", "city": "Cary", "address_1": "3909 3 Oaks Rd", "reason_for_recall": "Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products", "address_2": "", "product_quantity": "10505 Cases", "code_info": "Product Code: 6572; Lots: 52349, 52367, 52370, 52438, EXP 10/03/2017; 52457, 52471, EXP 10/17/2017; 53106, EXP 11/14/2017; 53569, EXP 12/19/2017; 53945, EXP 01/30/2018; 54354, EXP 02/20/2018; 54950, EXP 03/28/2018; 55452, EXP 04/24/2018; 56131, EXP 06/12/2018; 56901, EXP 07/31/2018; 57791, EXP 09/18/2018; 58455, EXP 10/24/2018; 59447, EXP 12/11/2018; 59869, EXP 01/08/2019; 60887, EXP 03/12/2019; 61883, EXP 04/30/2019.", "center_classification_date": "20180209", "distribution_pattern": "Distributed Nationwide in the USA and Puerto Rico,  Canada, United Kingdom, Ireland, Netherlands, New Zealand", "state": "IL", "product_description": "Toothette Oral Care Suction Toothbrush with Perox-A-Mint solution and Mouth Moisturizer. Contains 1 Suction Toothbrush with sodium Bicarbonate, 0.25 fl oz /7ml Perox-A-Mint solution, 0.07 oz/2g Mouth Moisturizer, 1 Applicator Swab, Sage Products, Inc., 3909 Three Oaks Road, Cary, IL 60013. Product Code 6572", "report_date": "20180221", "classification": "Class II", "openfda": {}, "recalling_firm": "Sage Products Inc", "recall_number": "D-0384-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77992", "termination_date": "20181213", "more_code_info": "", "recall_initiation_date": "20170822", "postal_code": "60013-1804", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82398", "recalling_firm": "Advanced Pharma Inc.", "address_1": "9265 Kirby Dr", "address_2": "N/A", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1020-2019", "product_description": "Phenylephrine HCl, 500 mcg in 0.9% Sodium Chloride, QS 5 mL Injectable Solution 500 mcg/5 mL (100 mcg per mL), 5mL Sterile single use syringe, NDC: 42852-830-67 Avella of Houston 9265 Kirby Dr., Houston, TX 77054 (877) 794-0404", "product_quantity": "16075 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190313", "center_classification_date": "20190321", "termination_date": "20200114", "report_date": "20190327", "code_info": "Lots: 01/18/19 3261 83067S Exp. 6/17/2019; 10/18/18 0212 83067S Exp. 3/17/2019; 10/23/18 7704 83067S Exp. 3/22/2019; 11/02/18 5909 83067S Exp. 4/1/2019; 10/31/18 8995 83067S Exp. 3/30/2019; 10/22/18 2570 83067S Exp. 3/21/2019; 10/18/18 6471 83067S Exp. 3/17/2019; 11/05/18 5527 83067S Exp. 4/4/2019; 11/05/18 0985 83067S Exp. 4/4/2019; 10/22/18 9234 83067S Exp. 3/21/2019; 10/30/18 6678 83067S Exp. 3/29/2019"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77822", "recalling_firm": "Akorn Inc", "address_1": "1925 W Field Ct", "address_2": "N/A", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1088-2017", "product_description": "Chlorhexidine Gluconate Oral Rinse, 0.12%, 15 mL Unit Dose Cup, a) unit dose cup (NDC 50383-720-15), b) 100-count tray (NDC 50383-720-19), Rx Only, Hi-Tech Pharmacal Co. Inc., Amityville, NY 11701.", "product_quantity": "541,900 unit dose cups (5,419 trays)", "reason_for_recall": "Crystallization with subpotent out of  specification assay results for chlorhexidine.", "recall_initiation_date": "20170712", "center_classification_date": "20170814", "termination_date": "20180619", "report_date": "20170823", "code_info": "Lot: 353394, Exp 10-2018"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1028-2023", "product_description": "CARDIOPLEGIA SOLUTION, 60 mEq K, Induction 4:1, High Potassium, IV Bag, total volume = 830 mL, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0100-1", "product_quantity": "196 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-251685, Exp. 7/15/2023; 36-252364, 7/17/2023"}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89798", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0671-2022", "product_description": "Clobetasol Propionate Cream USP, 0.05% (Emollient), packaged in a) 15 grams tube, NDC 52565-094-15; b) 30 grams tube, NDC 52565-094-30; c) 45 grams tube, NDC 52565-094-45; d) 60 grams tube, NDC 52565-094-60, Rx only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310.", "product_quantity": "105,200 tubes", "reason_for_recall": "cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.", "recall_initiation_date": "20220315", "center_classification_date": "20220321", "termination_date": "20240617", "report_date": "20220330", "code_info": "Batch: a) 15377, Exp. 3/31/2022; 15927, Exp. 9/30/2022; 16130, Exp. 11/30/2022; b) 15117, Exp. 2/28/2022; 16028, Exp. 9/30/2022; 16945, Exp. 5/31/2023; c) 15377, Exp. 3/31/2022; 15927, Exp. 9/30/2022; 16683, Exp. 5/31/2022; d) 15116, Exp. 2/28/2022; 15117, Exp. 2/28/2022; 16130, Exp. 11/30/2022; 16228, Exp. 11/30/2022; 16348, Exp. 1/31/2023"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72455", "recalling_firm": "Downing Labs, LLC", "address_1": "4001 McEwen Rd Suite 110", "address_2": "N/A", "postal_code": "75244-5020", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the US; Australia, Brazil, Bahamas, Switzerland, France, Colombia, Hong Kong, Indonesia, India, Japan, Malaysia, New Zealand, Phillippines, Singapore, Thailand, Trinidad and Tobago, Taiwan", "recall_number": "D-0369-2016", "product_description": "DMSO 99% Injection, 50mL vial, Rx only, Downing Labs, LLC 4001 McEwen Rd, Suite 110, Dallas TX, 754244, 1-800-914-7435", "product_quantity": "187 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20151016", "center_classification_date": "20151118", "termination_date": "20160922", "report_date": "20151125", "code_info": "All lots"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: SODIUM CHLORIDE, Tablet, 1 mg may have potentially been mislabeled as one of the following drugs:  BISACODYL EC, Tablet, 5 mg, NDC 00904792760, Pedigree: AD34931_1, EXP: 5/9/2014;  DUTASTERIDE, Capsule, 0.5 mg, NDC 00173071215, Pedigree: AD70633_1, EXP: 5/29/2014;  OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 00904404360, Pedigree: W002509, EXP: 6/3/2014;  SODIUM CHLORIDE, Tabl", "address_2": "", "product_quantity": "7891 Tablets", "code_info": "SODIUM CHLORIDE, Tablet, 1 mg has the following codes:   Pedigree: AD39560_1, EXP: 5/13/2014;  Pedigree: AD70636_1, EXP: 5/29/2014;  Pedigree: AD73662_1, EXP: 6/3/2014;  Pedigree: W002611, EXP: 6/4/2014;  Pedigree: W003792, EXP: 6/27/2014;  Pedigree: AD22845_10, EXP: 5/2/2014;  Pedigree: W003115, EXP: 6/13/2014;  Pedigree: W003707, EXP: 6/25/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "SODIUM CHLORIDE, Tablet, 1 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00223176001.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-883-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0270-2018", "product_description": "Medline Wound Closure Tray, Sterile, Single use only. Packaged in Mexico for Medline Industries, Inc., Northfield, IL 60093", "product_quantity": "80 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: DYNDA1465; Lots: 17HB4903; 17CB8548", "more_code_info": ""}, {"status": "Terminated", "city": "Suffern", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA010187"], "brand_name": ["RITALIN"], "generic_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "product_ndc": ["0078-0439", "0078-0440", "0078-0441"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "rxcui": ["1091150", "1091379", "1091392", "1091395", "1091497", "1091500"], "spl_id": ["00db4d6e-410b-43a1-ab5e-7047f525e68d"], "spl_set_id": ["c0bf0835-6a2f-4067-a158-8b86c4b0668a"], "package_ndc": ["0078-0439-05", "0078-0440-05", "0078-0441-05"], "is_original_packager": [true], "upc": ["0300780441056", "0300780439053"], "unii": ["4B3SC438HI"]}, "product_type": "Drugs", "event_id": "67633", "recalling_firm": "Novartis Pharmaceuticals Corp.", "address_1": "25 Old Mill Rd", "address_2": "N/A", "postal_code": "10901-4106", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1227-2014", "product_description": "Ritalin HCl (methylphenidate HCl) USP, 10 mg, 100 tablets per Bottle, Rx only, Mfd. by: Novartis Pharmaceuticals Corp. Suffern, NY 10901, Dist. by: Novartis Pharmaceuticals Corp. East Hanover, New Jersey 07936, NDC 0078-0440-05", "product_quantity": "10,930 Bottles", "reason_for_recall": "Labeling: Incorrect or Missing Package Insert; The back of the Medication Guide attached to the Package Insert for Ritalin Tablets was printed with information related to Ritalin SR (Sustained Release) Tablets.  Both products, Ritalin Tablets and Ritalin SR Tablets utilize a combined Package Insert.  The individual Medication Guides are attached to the Package Insert via a perforation.  Although t", "recall_initiation_date": "20140303", "center_classification_date": "20140408", "termination_date": "20141202", "report_date": "20140416", "code_info": "Lot #: F0126"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0381-2017", "product_description": "NADH/Carnitine/Taurine/B12(M) Injectable, 100 mg/150 mg/150 mg/10 mg, Lyophilized Kit, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "219 kits (number of vials per kit vary by prescription)", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known kit lot code: 04072016@29, 08122016@103.  Known vial lot code: 03302016@13, 03252016@16, 08082016@58, 08082016@67."}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0456-2020", "product_description": "CVS Health Lubricating Gel Drops for Anytime Use, Item#: 563420, Product Size: 10 mL, Distributed by: CVS Pharmacy, Inc. One CVS Drive, Woonsocket, RI 02895", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "17238 08/19   18094 4/20   19058 02/21"}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0142-2016", "product_description": "TESTOSTERONE CYPIONATE FOR SUBQ INJECTION, Injectable Solution, 100 mg/mL, 10mL syringe, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "1 syringe", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t12102014@3, t06252015@37"}, {"status": "Terminated", "city": "Birmingham", "state": "AL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["NINJACOF"], "generic_name": ["CHLOPHEDIANOL HCL AND PYRILAMINE MALEATE"], "manufacturer_name": ["Centurion Labs, LLC"], "product_ndc": ["23359-032"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["CHLOPHEDIANOL HYDROCHLORIDE", "PYRILAMINE MALEATE"], "rxcui": ["1593749", "1593756"], "spl_id": ["2a306ef4-c68d-8904-e063-6294a90a32a0"], "spl_set_id": ["e2bca40f-9c27-ec8b-2ff0-ef9847ba2037"], "package_ndc": ["23359-032-16", "23359-032-10", "23359-032-04"], "is_original_packager": [true], "unii": ["69QQ58998Y", "R35D29L3ZA"]}, "product_type": "Drugs", "event_id": "77990", "recalling_firm": "Centurion Labs, LLC", "address_1": "3100 Bowling Dr", "address_2": "Suite 1", "postal_code": "35242-6588", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide.", "recall_number": "D-1140-2017", "product_description": "Ninjacof (Chlophedianol HCL 12.5 mg and Pyrilamine Maleate 12.5 mg) Oral Solution, 16 fl. oz. (473 mL), Cotton Candy Flavor,  Manufactured for: Centurion Labs, LLC Birmingham, AL 35243 --- NDC 23359-032-16", "product_quantity": "4149 bottles", "reason_for_recall": "Microbial contamination of Non-sterile Products; potential B. cepacia contamination", "recall_initiation_date": "20170822", "center_classification_date": "20170912", "termination_date": "20200914", "report_date": "20170920", "code_info": "Lot: 200N1601 Exp. 11/2018"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA040422"], "brand_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "generic_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0555-0775", "0555-0971", "0555-0972", "0555-0776", "0555-0777", "0555-0973", "0555-0974"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMPHETAMINE ASPARTATE MONOHYDRATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE"], "rxcui": ["541363", "541878", "541892", "577957", "577961", "687043", "1009145"], "spl_id": ["88468f3d-7d03-4cee-aabf-3abc8c9b5e38"], "spl_set_id": ["cffbbb15-d776-41ae-a8a6-687f2c07bfa4"], "package_ndc": ["0555-0971-02", "0555-0775-02", "0555-0972-02", "0555-0776-02", "0555-0777-02", "0555-0973-02", "0555-0974-02"], "is_original_packager": [true], "unii": ["JJ768O327N", "O1ZPV620O4", "6DPV8NK46S", "G83415V073"]}, "product_type": "Drugs", "event_id": "90803", "recalling_firm": "Teva Pharmaceuticals USA Inc", "address_1": "400 Interpace Pkwy Bldg A", "address_2": "", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US.", "recall_number": "D-1539-2022", "product_description": "Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product), 15 mg, Rx Only, 100 tablets per bottle, Teva Pharmaceuticals USA, Inc. North Wales, PA 19454, NDC 0555-0777-02.", "product_quantity": "83,703 bottles", "reason_for_recall": "Labeling: Label Error on Declared Strength; A sealed 100-count bottle labeled with 15 mg actually contained 100 tablets of 20 mg strength of the drug product.", "recall_initiation_date": "20220829", "center_classification_date": "20220916", "termination_date": "20230814", "report_date": "20220921", "code_info": "Lot #: 100023340, Exp 10/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0196-2021", "product_description": "HYDROmorphone HCl 30 mg/30 mL in 0.9% Sodium Chloride Injection (1 mg/mL) a) 30 mL Plungerless Single Dose Syringe (barcode 70004030316) and b) 30 mL Single Dose Syringe (barcode 70004030321), Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095", "product_quantity": "1,056 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "a) Lot # 1220022964, BUD 1/19/2021; 1220023280, BUD 2/1/2021 &  1220023623, BUD 2/10/2021.  b) Lot # 1220023347, BUD 2/17/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090034"], "brand_name": ["RIFAMPIN"], "generic_name": ["RIFAMPIN"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["60687-575", "60687-586"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["RIFAMPIN"], "rxcui": ["198201", "198202"], "spl_id": ["3cd2b6a6-7724-43a5-e063-6294a90a3058"], "spl_set_id": ["50f706f9-5003-4e15-bece-85b6213b1f5c"], "package_ndc": ["60687-586-11", "60687-586-01", "60687-575-11", "60687-575-21"], "original_packager_product_ndc": ["68180-659", "68180-658"], "nui": ["N0000175500", "M0019113"], "pharm_class_epc": ["Rifamycin Antibacterial [EPC]"], "pharm_class_cs": ["Rifamycins [CS]"], "unii": ["VJT6J7R4TR"]}, "product_type": "Drugs", "event_id": "91416", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0165-2023", "product_description": "Rifampin Capsules USP, 300 mg, 100 Capsules (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC 60687-586-01 (Individual Dose NDC: 60687-586-11)", "product_quantity": "3,091 cartons", "reason_for_recall": "Failed Impurities/Degradations Specifications", "recall_initiation_date": "20221220", "center_classification_date": "20230118", "termination_date": "20240906", "report_date": "20230125", "code_info": "Lot #: 1007805, exp. 12/31/2023"}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0091-2016", "product_description": "FOLIC ACID, Injectable Solution, 10 mg/mL, 30 mL syringe, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "6 syringes", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t02182015@36, t03052015@23, t03302015@17, t05132015@33, t06192015@20,"}, {"country": "United States", "city": "Sugar Land", "address_1": "1075 W Park One Dr Ste 100", "reason_for_recall": "Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules", "address_2": "", "product_quantity": "", "code_info": "Lots: 10029289 Exp. 11/14/2019    10029841 Exp. 11/19/2019,    10029861 Exp. 11/19/2019,    10029863 Exp. 11/19/2019,      10030008 Exp. 11/24/2019,  10029946 Exp. 11/21/2019,    10030009 Exp. 11/24/2019,    10030010 Exp. 11/24/2019,    10030483 Exp. 11/27/2019,    10030482 Exp. 11/27/2019,  ,  10030958 Exp. 12/3/2019,  ,  10030908 Exp. 12/2/2019,    10030430 Exp. 11/26/2019,    10030989 Exp. 12/4/2019,    10030959 Exp. 12/3/2019,    10030907 Exp. 12/2/2019,    10030908 Exp. 12/2/2019,    10031283 Exp. 12/11/2019,    10031345 Exp. 12/12/2019,    10031346 Exp. 12/12/2019,    10031477 Exp. 12/16/2019,  10031433 Exp. 12/15/2019,    10031434 Exp. 12/15/2019,    10031478 Exp. 12/16/2019,    10031568 Exp. 12/18/2019,  10031615 Exp. 12/19/2019,    10031479 Exp. 12/18/2019,    10031568 Exp. 12/18/2019,    10031569 Exp. 12/18/2019,  10031570 Exp. 12/18/2019,    10031642 Exp. 12/20/2019,    10031591 Exp. 12/19/2019,    10031813 Exp. 12/23/2019,    10031814 Exp. 12/23/2019,    10032008 Exp. 12/27/2019,    10032009 Exp. 12/27/2019,    10031759 Exp. 12/26/2019,  10031946 Exp. 12/26/2019,  10031846 Exp. 12/24/2019,  10032250 Exp. 12/30/2019,    10031845 Exp. 12/24/2019,    10031846 Exp. 12/24/2019,    10032366 Exp. 1/1/2020,    10032391 Exp. 1/1/2020,  ,  10032333 Exp. 12/31/2019,    10032445 Exp. 1/2/2020,    10031760 Exp. 1/7/2020,  10031975 Exp. 12/29/2019,  10031760 Exp. 1/7/2020,    10032533 Exp. 1/7/2020,  10031975 Exp. 12/29/2019,  10031976 Exp. 12/29/2019,    10031977 Exp. 12/29/2019,    10031760 Exp. 1/7/2020,  10032533 Exp. 1/7/2020,  10031976 Exp. 12/29/2019,    10031977 Exp. 12/29/2019,  10032664 Exp. 1/8/2020,    10032665 Exp. 1/8/2020,    10032533 Exp. 1/7/2020,  ,  10032614 Exp. 1/7/2020,    10032615 Exp. 1/7/2020", "center_classification_date": "20191203", "distribution_pattern": "Nationwide.", "state": "TX", "product_description": "fentaNYL 500 mcg/250 mL (2 mcg/mL) 0.125% BUPivacaine HCl 312.5 mg/250 mL (1.25 mg/mL) in 0.9% Sodium Chloride 250 mL Bag, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478  NDC 70092-1105-37", "report_date": "20191211", "classification": "Class II", "openfda": {}, "recalling_firm": "QuVa Pharma, Inc.", "recall_number": "D-0547-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84263", "termination_date": "20200605", "more_code_info": "", "recall_initiation_date": "20191112", "postal_code": "77478-2576", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Rockford", "address_1": "4901 Hiawatha Dr", "reason_for_recall": "Presence of Particulate Matter", "address_2": "", "product_quantity": "a) 35,197 vials; b) 21,302 vials", "code_info": "Lot #: a) 7801396, 7801398, 7801401, 7801406, Exp 08/16; 7801427, Exp 09/16; b) 7801089, 7801084, Exp 07/15; 7801110, Exp 08/15", "center_classification_date": "20150814", "distribution_pattern": "Nationwide and Puerto Rico", "state": "IL", "product_description": "Gemcitabine for Injection, USP, 200 mg*/vial, Lyophilized powder in a Single-Use Vial, Rx only, labeled as a) Manufactured for: Mylan Institutional LLC, Rockford, IL  61103, Made in India, NDC 67457-464-20, UPC 3 67457 46420 6; and b) Distributed by Pfizer Labs, Division of Pfizer Inc, New York, NY  10017, Made in India, NDC 0069-3857-10, UPC 3 00693 85710 4.", "report_date": "20150826", "classification": "Class I", "openfda": {}, "recalling_firm": "Mylan Institutional LLC", "recall_number": "D-1332-2015", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "71004", "termination_date": "20160520", "more_code_info": "", "recall_initiation_date": "20150323", "postal_code": "61103-1287", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Tonawanda", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93154", "recalling_firm": "Pine Pharmaceuticals, LLC", "address_1": "355 Riverwalk Pkwy", "address_2": "N/A", "postal_code": "14150-5837", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0053-2024", "product_description": "Calcium Gluconate Ophthalmic Irrigation Solution 1%,  500 mL bags, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.", "product_quantity": "128 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231002", "center_classification_date": "20231019", "termination_date": "20240515", "report_date": "20231025", "code_info": "Lot #: 69802, Exp. Date 02/28/2024"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71104", "recalling_firm": "Wockhardt Usa Inc.", "address_1": "20 Waterview Blvd Ste 3", "address_2": "N/A", "postal_code": "07054-1271", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide including Puerto Rico.", "recall_number": "D-1244-2015", "product_description": "Lisinopril Tablets USP, 2.5 mg Tablets, Packaged in A) 100 Count Bottles (NDC: 64679-927-01) and B) 500 Count Bottles (NDC: 64679-927-05), Rx Only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA.", "product_quantity": "A) 149,924 Bottles and B) 35,012 Bottles", "reason_for_recall": "CGMP Deviations: Firm did not adequately investigate customer complaints.", "recall_initiation_date": "20150422", "center_classification_date": "20150717", "termination_date": "20180509", "report_date": "20150729", "code_info": "A) Lot #: DM10573, Expiry: 4/30/2015; Lot #: DM11531, Expiry: 5/31/2015; Lot #: DM11532, Expiry: 5/31/2015; Lot #: DM11676, Expiry: 6/30/2015; Lot #: DM11677, Expiry: 6/30/2015; Lot #: DM12543, Expiry: 8/31/2015; Lot #: DM13333, Expiry: 11/30/2015; Lot #: DN10272, Expiry: 12/31/2015; Lot #: DN10405, Expiry: 12/31/2015; Lot #: DN10446, Expiry: 1/1/2016.  B) Lot #: DM11122, Expiry: 4/30/2015; Lot #: DM11130, Expiry: 4/30/2015; Lot #: DM11533, Expiry: 5/31/2015; Lot #: DM11674, Expiry: 6/30/2015; Lot #: DM11675, Expiry: 6/30/2015; Lot #: DM12497, Expiry: 8/31/2015; Lot #: DM13336, Expiry: 11/30/2015; Lot #: DN10289, Expiry: 12/31/2015; Lot #: DN10445, Expiry: 1/31/2016; Lot #: DN10816, Expiry: 1/31/2016; Lot #: DN10817, Expiry: 1/31/2016; Lot #: DN10976, Expiry: 2/29/2016."}, {"status": "Terminated", "city": "Verna, Salcette, Goa", "state": "", "country": "India", "classification": "Class III", "openfda": {"application_number": ["ANDA078169"], "brand_name": ["ESCITALOPRAM"], "generic_name": ["ESCITSLOPRAM"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-137", "68180-135", "68180-136"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ESCITALOPRAM OXALATE"], "rxcui": ["349332", "351249", "351250"], "spl_id": ["a752cb19-7de3-4b6d-aa44-03b7027ea60b"], "spl_set_id": ["41f7392a-1f5c-4542-9c5c-f9e109851381"], "package_ndc": ["68180-137-01", "68180-137-06", "68180-135-01", "68180-136-01"], "is_original_packager": [true], "upc": ["0368180135012", "0368180136019"], "unii": ["5U85DBW7LO"]}, "product_type": "Drugs", "event_id": "74944", "recalling_firm": "Lupin Limited", "address_1": "15-B, Phase 1A, Verna Industrial Area", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1516-201", "product_description": "Escitalopram Tablets USP 20 mg, 100-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Baltimore, MD, 21202, Manufactured by: Lupin Limited, Goa 403 722, India, NDC 68180-136-01", "product_quantity": "3,192 bottles (319,200 tablets)", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Expiration Date", "recall_initiation_date": "20160324", "center_classification_date": "20160921", "termination_date": "20170315", "report_date": "20160928", "code_info": "Lot # G510086; Exp. 11/17", "more_code_info": ""}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA020734"], "brand_name": ["CLINIMIX"], "generic_name": ["LEUCINE, PHENYLALANINE, LYSINE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, SERINE, TYROSINE, DEXTROSE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-0180", "0338-1133", "0338-1089", "0338-1134", "0338-1091", "0338-1137", "0338-1099", "0338-1138", "0338-1101", "0338-0198", "0338-0188", "0338-0194", "0338-0184", "0338-7001", "0338-7003", "0338-7005", "0338-7007", "0338-7009", "0338-7011", "0338-7013", "0338-7015"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["ALANINE", "ARGININE", "DEXTROSE", "GLYCINE", "HISTIDINE", "ISOLEUCINE", "LEUCINE", "LYSINE", "METHIONINE", "PHENYLALANINE", "PROLINE", "SERINE", "THREONINE", "TRYPTOPHAN", "TYROSINE", "VALINE"], "rxcui": ["800401", "800405", "800416", "800420", "800434", "800438", "800440", "800444"], "spl_id": ["f39f992f-7a22-46f6-9241-f03d349b95d9"], "spl_set_id": ["dccff103-8695-400c-a15d-cc2fd078760a"], "package_ndc": ["0338-1133-03", "0338-1089-04", "0338-1134-03", "0338-1091-04", "0338-1137-03", "0338-1099-04", "0338-1138-03", "0338-1101-04", "0338-0198-01", "0338-0198-06", "0338-0188-01", "0338-0188-06", "0338-0194-01", "0338-0194-04", "0338-0180-01", "0338-0180-06", "0338-0184-01", "0338-0184-04", "0338-7001-01", "0338-7001-06", "0338-7003-01", "0338-7003-04", "0338-7005-01", "0338-7005-06", "0338-7007-01", "0338-7007-04", "0338-7009-01", "0338-7009-06", "0338-7011-01", "0338-7011-04", "0338-7013-01", "0338-7013-06", "0338-7015-01", "0338-7015-04"], "is_original_packager": [true], "nui": ["N0000175780", "M0000922"], "pharm_class_epc": ["Amino Acid [EPC]"], "pharm_class_cs": ["Amino Acids [CS]"], "unii": ["9DLQ4CIU6V", "452VLY9402", "47E5O17Y3R", "42HK56048U", "IY9XDZ35W2", "OF5P57N2ZX", "94ZLA3W45F", "8DUH1N11BX", "HG18B9YRS7", "TE7660XO1C", "AE28F7PNPL", "GMW67QNF9C", "K3Z4F929H6", "2ZD004190S", "04Y7590D77", "4QD397987E"]}, "product_type": "Drugs", "event_id": "67107", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "1 Baxter Pkwy", "address_2": "", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide", "recall_number": "D-1160-2014", "product_description": "Clinimix 5/15 sulfite-free (5% Amino Acid in 15% Dextrose) Injection, 2000 mL CLARITY Dual Chamber Container bag, Rx only.  Dist: Baxter Healthcare Corporation, One Baxter Parkway, Deerfield, IL 60015. NDC: 0338-1099-04.", "product_quantity": "7,388 bags", "reason_for_recall": "Presence of Particulate Matter: Particulate matter includes wood, sodium citrate and dextrose.", "recall_initiation_date": "20131118", "center_classification_date": "20140314", "termination_date": "20160920", "report_date": "20140326", "code_info": "Lot# P285122, Exp 5/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-879-2015", "product_description": "Ribavirin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "2000 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "71846", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1354-2015", "product_description": "EPINEPHrine HCl 1 mg added to 250 mL 0.9% Sodium Chloride Injection USP (4 mcg per mL), packaged in 250 mL bags, Rx only, PharMEDium Services, LLC, 12620 W. Airport Blvd #130, Sugar Land, TX  77478, Service Code 2K6244, NDC# 61553-244-61.", "product_quantity": "36 bags", "reason_for_recall": "Presence of Particulate Matter: The firm produced products using 0.9% Sodium Chloride Injection, USP or 5% Dextrose Injection, USP which were subsequently recalled by the manufacturer due to the presence of particulate matter.", "recall_initiation_date": "20150413", "center_classification_date": "20150825", "termination_date": "20170123", "report_date": "20150902", "code_info": "Lot #: 15033045S, Exp 05/03/15"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; HYDROcodone BITARTRATE/ ACETAMINOPHEN, Tablet, 7.5 mg/325 mg may be potentially mislabeled as    MELATONIN, Tablet, 3 mg, NDC 51991001406, Pedigree: W003999, EXP: 7/1/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "HYDROcodone BITARTRATE/ ACETAMINOPHEN, Tablet, 7.5 mg/325 mg has the following code    Pedigree: W004005, EXP: 7/1/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "HYDROcodone BITARTRATE/ ACETAMINOPHEN Tablet, 7.5 mg/325 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 52544016201", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-609-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89938", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0827-2022", "product_description": "Sincalide. Lyophilized powder for reconstitution. 5 mcg per Multi-Dose vial, Rx Only, Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0082-00.", "product_quantity": "1770 vials", "reason_for_recall": "CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated", "recall_initiation_date": "20220404", "center_classification_date": "20220427", "termination_date": "20240617", "report_date": "20220504", "code_info": "Lots: F24018 BUD: 6/18/2022 and G47021 BUD: 7/21/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Palm Desert", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "72089", "recalling_firm": "Guthy-Renker LLC", "address_1": "41550 Eclectic St", "address_2": "N/A", "postal_code": "92260-1967", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide including Puerto Rico and Guam; Canada.", "recall_number": "D-0002-2016", "product_description": "Rodan & Fields Proactiv Solution, Sheer Finish Compact Foundation, salicylic acid acne treatment, LIGHT, 7 g/0.25 OZ. Compacts, Over the Counter. Manufactured for Guthy-Renker  Palm Desert, CA 92250.", "product_quantity": "29,341 Compacts", "reason_for_recall": "Subpotent Drug: Salicylic acid is subpotent.", "recall_initiation_date": "20120507", "center_classification_date": "20151001", "termination_date": "20151002", "report_date": "20151007", "code_info": "Lot #: N0054A, Expiry: 02/12; Lot #: N0055A, Expiry: 02/12; Lot #: N0201A, Expiry: 07/12; Lot #: N0202A, Expiry: 07/12; Lot #: N0351A, Expiry: 12/12; Lot #: N0354A, 12/12; Lot #: N0355A, Expiry: 12/12;  Lot #: N1033A, Expiry: 02/13; Lot #:  N1046A, Expiry: 02/13; Lot #: N1108A, Expiry: 04/13; Lot #: N1291A, Expiry: 10/13; Lot #: N1319A, Expiry: 11/13; Lot #: N1320A, Expiry: 11/13."}, {"status": "Terminated", "city": "Madison", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M018"], "brand_name": ["REFRESH RELIEVA PRESERVATIVE FREE"], "generic_name": ["CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN"], "manufacturer_name": ["Allergan, Inc."], "product_ndc": ["0023-6634"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["CARBOXYMETHYLCELLULOSE SODIUM", "GLYCERIN"], "rxcui": ["1100650"], "spl_id": ["c6440fb1-2b9b-4531-90e5-32fd270915b7"], "spl_set_id": ["3481f9b3-5a90-40d3-80f8-81f51cc864be"], "package_ndc": ["0023-6634-10", "0023-6634-01", "0023-6634-20"], "is_original_packager": [true], "nui": ["N0000185370", "N0000175629", "N0000184306", "N0000185001", "M0000728", "M0009417"], "pharm_class_epc": ["Non-Standardized Chemical Allergen [EPC]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]", "Increased IgG Production [PE]"], "pharm_class_cs": ["Allergens [CS]", "Glycerol [CS]"], "unii": ["K679OBS311", "PDC6A3C0OX"], "upc": ["300236634100"]}, "product_type": "Drugs", "event_id": "87016", "recalling_firm": "Allergan, PLC.", "address_1": "5 Giralda Farms", "address_2": "N/A", "postal_code": "07940-1027", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0233-2021", "product_description": "Refresh Relieva PF Preservative-Free Lubricant Eye Drops 0.33 fl oz (10 mL) Sterile Distributed by: Allergan, an AbbVie company Madison, NJ 07940 UPC 3 00236 63410 0, NDC 0023-6634-10.", "product_quantity": "100,634 bottles", "reason_for_recall": "Labeling: Missing instructions for use insert", "recall_initiation_date": "20201230", "center_classification_date": "20210119", "termination_date": "20230621", "report_date": "20210127", "code_info": "Lots: T0392 Exp. Jul. 2022, T0843 Exp. Aug. 2022", "more_code_info": ""}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077584"], "brand_name": ["PAROXETINE"], "generic_name": ["PAROXETINE"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["68084-044", "68084-045", "68084-046", "68084-047"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PAROXETINE HYDROCHLORIDE"], "rxcui": ["1738483", "1738495", "1738503", "1738511"], "spl_id": ["3f163cc0-999c-9fdd-e063-6394a90ac15e"], "spl_set_id": ["b5a8f864-a53d-48d9-aca6-6b64017fb168"], "package_ndc": ["68084-044-11", "68084-044-01", "68084-045-11", "68084-045-01", "68084-046-11", "68084-046-01", "68084-047-11", "68084-047-01"], "original_packager_product_ndc": ["68382-097", "68382-098", "68382-099", "68382-001"], "unii": ["X2ELS050D8"]}, "product_type": "Drugs", "event_id": "78490", "recalling_firm": "Amerisource Health Services", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0091-2018", "product_description": "Paroxetine Tablets, USP, 30mg, 100 tablets (10 x 10) , Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Columbus, Ohio 43217, NDC 68084-046-01", "product_quantity": "74 cartons (cartons of 100 individual unit doses)", "reason_for_recall": "Presence of Foreign Tablets/Capsules.", "recall_initiation_date": "20171024", "center_classification_date": "20171121", "termination_date": "20180619", "report_date": "20171129", "code_info": "Lot 172291"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0573-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Advanced First Aid, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955511823, NDC 57955-6000-2", "product_quantity": "1031 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot Numbers: 021516A Exp. 02/19; 050216K Exp. 05/19; 081315Q exp. 08/18"}, {"status": "Ongoing", "city": "Burbank", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA200675"], "brand_name": ["LIDOCAINE"], "generic_name": ["LIDOCAINE"], "manufacturer_name": ["Bryant Ranch Prepack"], "product_ndc": ["63629-8755"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["LIDOCAINE"], "rxcui": ["1745091"], "spl_id": ["1e774599-aaba-40c5-a05a-e36674660b8c"], "spl_set_id": ["1d28d687-695e-4cd9-97e2-7d4fdab9772a"], "package_ndc": ["63629-8755-2", "63629-8755-1", "63629-8755-20"], "original_packager_product_ndc": ["0591-3525"], "nui": ["N0000175682", "M0000897", "N0000175426", "N0000175976"], "pharm_class_epc": ["Amide Local Anesthetic [EPC]", "Antiarrhythmic [EPC]"], "pharm_class_cs": ["Amides [CS]"], "pharm_class_pe": ["Local Anesthesia [PE]"], "unii": ["98PI200987"]}, "product_type": "Drugs", "event_id": "92161", "recalling_firm": "Bryant Ranch Prepack, Inc.", "address_1": "1919 N Victory Pl", "address_2": "", "postal_code": "91504-3425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0556-2023", "product_description": "Lidocaine Patch 5%, 1 patch (63629-8755-20) packaged in 30-count patches per carton (63629-8755-1), Rx only, each patch contains: 700 mg (50mg per gram adhesive) in an aqueous base, Manufactured by: Actavis Laboratories UT, Inc., Relabeled by: Bryant Ranch Prepack, Inc. Burbank, CA 91504 USA", "product_quantity": "403 boxes", "reason_for_recall": "Labeling: Typographical error on the upper left-hand side of the box and individual patch label that has the incorrect dosage form stating, each tablet contains instead of each adhesive patch contains.", "recall_initiation_date": "20230420", "center_classification_date": "20230428", "report_date": "20230510", "code_info": "Lot: 204603, Exp: 09/30/2024; Lots:208608, 208749, 208445, 209101, 208609, 208295, 209106, 209102, 209212, 208975, 209211, 209706, 209779, 209624, 209839, 209548, Exp: 12/31/2024; Lots: 204604, 204601, 204550, 204599, 204871, 204555, 205616, Exp: 11/30/2024; Lots: 205612, 204832, 205127, 204996, 205615, 205324, 205494, 205611, 206232, Exp: 10/31/2024.", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "38 units", "code_info": "Rx #'s:   0396112    0396112    0390633    0399923    0392295    0397930    0405691    0357875    0371933      0370806      0371933      0357875    0371933      0373258    0373258    0373258    0391775      0397909    0391540    0371152    0401946    0409588    0391886              0391886    0391886    0391886    0391867    0400517", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "VITAMIN  K (PHYTONADIONE) 10MG/ML INJECTABLE\t1 ML  \t2 ML  \t4 ML;  VITAMIN  K (PHYTONADIONE) 5MG/ML INJECTABLE\t2 ML;  VITAMIN A AQUEOUS EMULSION 50,000 U/ML INJECTABLE\t20 ML  \t40 ML;  \t  VITAMIN B COMPLEX (B1,B2,B3,B5,B6) 100/5/100/100/100MG/ML INJECTABLE\t120 ML  \t  \t  \t150 ML  \t  \t  \t  \t180 ML  \t90 ML  \t  VITAMIN B COMPLEX (B1,B2,B3,B5,B6,B12)  INJECTABLE\t10 ML  \t20 ML  \t40 ML  VITAMIN B COMPLEX (B1,B2,B3,B5,B6/ASCORBIC ACID/B12) 12.5/2/12.5/5/5/1MG/1MG/ML \t60 ML  \t  VITAMIN B COMPLEX -PF  (B1,B2,B3,B5,B6) 12.5/12.5/12.5/12.5/12.5MG/ML INJECTABLE\t40 ML  VITAMIN B COMPLEX PF (B1,B2,B3,B5,B6,B12)  INJECTABLE\t10 ML  VITAMIN B-6/VITAMIN B-12 100MG/1000MCG/ML INJECTABLE\t5 ML  VITAMIN B-COMPLEX 100*** (30ML)  INJECTABLE\t30 ML  \t  VITAMIN COMPLEX (ASCOR,B1,B2,B3,B5,B6,B12,METH,INOS,CHL,LID) DR. HOLLOWAY INJECT\t180 ML  \t  \t  \t  \t  \t  \t240 ML  \t30 ML  \t60 ML  VITAMIN D3  IN SESAME OIL 10,000 IU/ML INJECTABLE\t60 ML  (23 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1641-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75164", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "MS", "recall_number": "D-1542-2016", "product_description": "Pre-Op Pledget Soln, Ophthalmic Drops (Tropicamide (1%) 0.33ml, Phenylephrine (10%) 0.66ml, Ketorolac (0.5%) 0.33ml, Ofloxacin (0.3) 0.67ml, 2ml vial, Rx, Vital Care Compounder, Hattiesburg, MS", "product_quantity": "6 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160726", "center_classification_date": "20160927", "termination_date": "20161118", "report_date": "20161005", "code_info": "Lot# 397267, Use by 9/20/16"}, {"status": "Ongoing", "city": "Irving", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA125544"], "brand_name": ["INFLECTRA"], "generic_name": ["INFLIXIMAB-DYYB"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["0069-0809"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["INFLIXIMAB"], "rxcui": ["1790541", "1790546"], "spl_id": ["421960f4-55cd-4bf8-9f00-b980b020e7a7"], "spl_set_id": ["37eaca10-d812-48bc-8b8e-b836bfa9968f"], "package_ndc": ["0069-0809-01"], "is_original_packager": [true], "upc": ["0300690809014"], "nui": ["N0000175610", "N0000175451"], "pharm_class_epc": ["Tumor Necrosis Factor Blocker [EPC]"], "pharm_class_moa": ["Tumor Necrosis Factor Receptor Blocking Activity [MoA]"], "unii": ["B72HH48FLU"]}, "product_type": "Drugs", "event_id": "96167", "recalling_firm": "McKesson", "address_1": "6555 State Highway 161", "address_2": "", "postal_code": "75039-2402", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0213-2025", "product_description": "Inflectra (infliximab-dyyb), For injection, 100mg per vial, packaged in 10 mL single-dose vial, Rx only, Mfd by: CELLTRION, INC, Dist. by: Pfizer Labs, Division of Pfizer Inc., New York, NY 10001, NDC 0069-0809-01", "product_quantity": "192 vials", "reason_for_recall": "cGMP Deviations: Product intended for quarantine was inadvertently distributed.", "recall_initiation_date": "20250117", "center_classification_date": "20250130", "report_date": "20250205", "code_info": "Lot# 04647349, Exp Date 5/31/2029", "more_code_info": ""}, {"status": "Terminated", "city": "Palm Harbor", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81810", "recalling_firm": "Promise Pharmacy, LLC", "address_1": "31818 Us Highway 19 N", "address_2": "N/A", "postal_code": "34684-3713", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0451-2019", "product_description": "Sermorelin/GHRP2/GHRP6 6mg/3mg/3mg injection, Rx Only, Promise Pharmacy Compounding Specialists 31818 US Hwy 19N, Palm Harbor, FL 34684", "product_quantity": "296 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20181217", "center_classification_date": "20190208", "termination_date": "20210330", "report_date": "20190220", "code_info": "Lots: 08302018@13 BUD: 2/26/2019; 09212018@14 BUD: 3/20/2019"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; DOXEPIN HCL Capsule, 150 mg may be potentially mislabeled as    VALSARTAN, Tablet, 160 mg, NDC 00078035934, Pedigree: AD46312_7, EXP: 5/16/2014.", "address_2": "", "product_quantity": "100 Capsules", "code_info": "DOXEPIN HCL, Capsule, 150 mg has the following code    Pedigree: AD46312_10, EXP: 5/16/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "DOXEPIN HCL Capsule, 150 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 49884022201", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-587-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "72 units", "code_info": "Lot #: 5/23/17 1404 299-92625P, BUD: 8/21/2017; 5/26/2017 1250 297-92625P, BUD 8/24/2017.", "center_classification_date": "20170707", "distribution_pattern": "Nationwide with the United States", "state": "TX", "product_description": "Potassium Phosphate (USP) QS 0.9% Sodium Chloride (USP) 250 mL 20 mmol in NS 250mL Bag, Advanced Pharma, 9265 Kirby Dr., Houston, TX 77054 (877) 794-0404. NDC15082-926-25", "report_date": "20170719", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0954-2017", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "77595", "termination_date": "20171206", "more_code_info": "", "recall_initiation_date": "20170622", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "65394", "recalling_firm": "Zydus Pharmaceuticals USA Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-838-2013", "product_description": "Warfarin Sodium Tablets, USP 2 mg,  Rx Only, 1000 Tablets per bottle,  Manufactured by: Cadila Healthcare Ltd Ahmedabad, India,  Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ  08534, NDC 68382-053-10", "product_quantity": "960 Bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications: A product complaint was received from a pharmacist who discovered that 3 tablets in a 1000-count bottle were oversized.", "recall_initiation_date": "20130513", "center_classification_date": "20130802", "termination_date": "20150505", "report_date": "20130814", "code_info": "Lot MM5767"}, {"status": "Ongoing", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA022430"], "brand_name": ["TRANEXAMIC ACID"], "generic_name": ["TRANEXAMIC ACID"], "manufacturer_name": ["AvPAK"], "product_ndc": ["50268-772"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TRANEXAMIC ACID"], "rxcui": ["883826"], "spl_id": ["0e7601e7-a14f-644a-e063-6394a90a5f80"], "spl_set_id": ["e8cdb0d6-9498-2902-e053-2995a90a9de4"], "package_ndc": ["50268-772-11", "50268-772-13"], "original_packager_product_ndc": ["69918-301"], "nui": ["N0000175634", "N0000175632"], "pharm_class_epc": ["Antifibrinolytic Agent [EPC]"], "pharm_class_pe": ["Decreased Fibrinolysis [PE]"], "unii": ["6T84R30KC1"]}, "product_type": "Drugs", "event_id": "92535", "recalling_firm": "AVKARE LLC", "address_1": "615 N 1st St", "address_2": "N/A", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0875-2023", "product_description": "Tranexamic Acid USP Tablets, 650 mg, 30 tablets (3X10) Unit Dose, Rx Only, Manufactured for: AvKARE Pulaski, TN 38478, NDC 50268-772-13", "product_quantity": "592 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.", "recall_initiation_date": "20230613", "center_classification_date": "20230615", "report_date": "20230621", "code_info": "Lot: 44286 Exp. 02/2025"}, {"status": "Ongoing", "city": "Canoga Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97558", "recalling_firm": "Private Label Skin Care Inc.", "address_1": "8200 Remmet Ave", "address_2": "N/A", "postal_code": "91304-4156", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA, GA only", "recall_number": "D-0666-2025", "product_description": "mel rx Skin, NO DRAMA Benzoyl Peroxide 10% Acne Treatment, 7 oz, 201 g Mel Skin Rx Beverly Hills, CA 90210", "product_quantity": "N/A", "reason_for_recall": "Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.", "recall_initiation_date": "20250912", "center_classification_date": "20250924", "report_date": "20251001", "code_info": "Lot # 58170A and 58172A, Exp Date: 09/2025", "more_code_info": ""}, {"country": "United States", "city": "Princeton", "address_1": "107 College Rd E", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Out-of-specification results for microbial count were observed at the initial stability interval for Lansoprazole Delayed Release Capsules.", "address_2": "", "product_quantity": "58,656 Bottles", "code_info": "Lot #: a) 79305114A, b) 79305114B, c) 79305114C, d) 79305114D, e) 79305114E, f) 79305114F, Exp 05/2015", "center_classification_date": "20140305", "distribution_pattern": "Nationwide", "state": "NJ", "product_description": "a) Walgreens Lansoprazole Delayed Release Capsules, USP 15 mg/Acid Reducer, 14 capsules per Bottle, Dist by Walgreen Company, 200 Wilmot RD Deerfield IL 60015  b) Family Wellness Lansoprazole Delayed Release Capsules, USP 15 mg/Acid Reducer, 14 capsules per Bottle, Distributed by Family Services Inc .10401 Monroe Road, Matthews, NC 28105 USA  c) CVS Pharmacy Lansoprazole Delayed Release Capsules, 15 mg, Acid Reducer, 14 safety sealed capsules per Bottle, Distributed by CVS/pharmacy Inc, One CVS Drive, Woonsocket, 02895  d) CVS Pharmacy Lansoprazole Delayed Release Capsules, 15 mg, Acid Reducer, 28 safety sealed capsules per Bottle, Distributed by CVS/pharmacy Inc, One CVS Drive, Woonsocket, 02895  e) Equate Lansoprazole Delayed-Release Capsules USP, 15 mg Acid Reducer, 14 capsules per Bottle, and 28 capsules per bottle (Twin Pack)Distributed by Wal-mart Stores Inc. Bentonville, AR 72716  f) CVS Pharmacy Lansoprazole Delayed Release Capsules, 15 mg, Acid Reducer, 42 safety sealed capsules per Bottle, Distributed by CVS/pharmacy Inc, One CVS Drive, Woonsocket, 02895", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "recall_number": "D-1146-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "67303", "termination_date": "20151120", "more_code_info": "", "recall_initiation_date": "20140103", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Waynesboro", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81811", "recalling_firm": "Duren Health Mart Pharmacy", "address_1": "215 Dexter L Woods Memorial Blvd", "address_2": "N/A", "postal_code": "38485-2416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "TN only", "recall_number": "D-0418-2019", "product_description": "Testosterone 0.1% cream, 30 grams, Rx only, Duren's Health Mart Pharmacy 215 Dexter Woods Blvd. Waynesboro, TN38485, NDC 00000-0000-98", "product_quantity": "300 grams", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20181217", "center_classification_date": "20190128", "termination_date": "20220119", "report_date": "20190206", "code_info": "N/A"}, {"country": "United States", "city": "Berkeley", "address_1": "2320 Woolsey St", "reason_for_recall": "Lack of Assurance of Sterility: Firm is recalling all unexpired lots of sterile compounded products after FDA inspection found concerns of lack of sterility assurance.", "address_2": "", "product_quantity": "35 ml", "code_info": "All lots", "center_classification_date": "20160217", "distribution_pattern": "CA", "state": "CA", "product_description": "methylcobalamine 4 mg/mL, 5 mL and 30 mL unit sizes, refrigerate, This Rx is Compounded, Abbott's Compounding Pharmacy, Berkeley, CA 94705", "report_date": "20160224", "classification": "Class II", "openfda": {}, "recalling_firm": "Abbott's Compounding Pharmacy, Inc.", "recall_number": "D-0687-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73090", "termination_date": "20170406", "more_code_info": "", "recall_initiation_date": "20160115", "postal_code": "94705-1973", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "61 ml total", "code_info": "All lots distributed between November 2014 and May 2015;  03242015@5, 5/23/2015; 05042015@78, 7/3/2015; 03262015@2, 5/25/2015; 04062015@52, 6/5/2015; 04242015@58, 6/23/2015; 05072015@17, 7/6/2015; 05082015@19, 7/7/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "HCG 2,500 IU/ml + Methylcobalamin 500 mcg/ml, Injection, Multi-Dose Vial, Sterile, Refrigerate, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1511-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82827", "recalling_firm": "Zydus Pharmaceuticals USA Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1443-2019", "product_description": "Pramipexole DihydrochlorideTablets 0.125 mg, 90-count bottle, Rx Only, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India. Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-196-16", "product_quantity": "143,184 90-count bottles", "reason_for_recall": "CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.", "recall_initiation_date": "20190506", "center_classification_date": "20190701", "termination_date": "20210916", "report_date": "20190626", "code_info": "Lot: M714176, M714177, EXP Oct-19; M714917, EXP Nov-19; M714918, M715594, M715595, EXP Dec-19; M802190, EXP Jan-20; M802191, EXP Feb-20, M808673, EXP May-20; M811125, M811126, M811127, M811128, M811129, EXP Jun-20; M815082, M815083, M815084, M815085, M815086 EXP Aug-20; M900476, M900477, M900478, M900479, M900481, Dec-20;"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "82510", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W Field Ct Ste 300", "address_2": "N/A", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "AR and MS", "recall_number": "D-1080-2019", "product_description": "Nystatin Oral Suspension, USP, 100,000 units per mL, 473 mL per bottle, Rx only, HI-TECH Pharmacal Co., Inc., Amityville, NY 11701, NDC 50383-587-16", "product_quantity": "2,796 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of Specification for an unknown impurity was observed during the 18 month stability testing.", "recall_initiation_date": "20190328", "center_classification_date": "20190404", "termination_date": "20200422", "report_date": "20190410", "code_info": "Lot#: 356527, Exp 3/19"}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021301"], "brand_name": ["LEVOXYL"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["60793-850", "60793-851", "60793-852", "60793-853", "60793-854", "60793-855", "60793-856", "60793-857", "60793-858", "60793-859", "60793-860"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "966157", "966164", "966170", "966175", "966184", "966190", "966194", "966200", "966204", "966211", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270", "966283"], "spl_id": ["e230c170-2a16-47d0-bce7-ac0414c192f7"], "spl_set_id": ["758588c3-c63e-491b-0aa2-4f50d80cb174"], "package_ndc": ["60793-850-10", "60793-850-01", "60793-851-10", "60793-851-01", "60793-852-10", "60793-852-01", "60793-853-10", "60793-853-01", "60793-854-10", "60793-854-01", "60793-855-10", "60793-855-01", "60793-856-10", "60793-856-01", "60793-857-10", "60793-857-01", "60793-858-10", "60793-858-01", "60793-859-10", "60793-859-01", "60793-860-10", "60793-860-01"], "is_original_packager": [true], "upc": ["0360793856018", "0360793850016", "0360793852010", "0360793851013", "0360793857015", "0360793853017", "0360793854014", "0360793858012", "0360793855011", "0360793859019", "0360793860015"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "65172", "recalling_firm": "King Legacy, a wholly owned subsidiary of Pfizer", "address_1": "501 5th Street", "address_2": "N/A", "postal_code": "37620-2304", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-426-2013", "product_description": "Levoxyl (levothyroxine sodium) tablets, USP, 112 mcg, packaged in a) 100-count bottles (NDC 60793-855-01) and b) 1000-count bottles (NDC 60793-855-10), Rx only, Manufactured and Distributed by:  King Pharmaceuticals, Inc., Bristol, TN  37620", "product_quantity": "107,236 bottles", "reason_for_recall": "Subpotent Drug: The products were below specification for potency at the expiry stability point.", "recall_initiation_date": "20130430", "center_classification_date": "20130520", "termination_date": "20160630", "report_date": "20130529", "code_info": "Lot # a) 64936, Exp. 5/13; 65634, Exp. 7/13; 66295, Exp. 9/13; 66669, Exp. 11/13; b) 65063, Exp. 5/13 and 65767, Exp. 7/13"}, {"country": "United States", "city": "Asheville", "address_1": "752 Biltmore Ave", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "All lot numbers within expiry.", "center_classification_date": "20140304", "distribution_pattern": "NC", "state": "NC", "product_description": "Tacrolimus 0.02% opth. (H20-based)", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Natures Pharmacy & Compounding Center", "recall_number": "D-1135-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66856", "termination_date": "20140424", "more_code_info": "", "recall_initiation_date": "20131101", "postal_code": "28803-2558", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Cleveland", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85217", "recalling_firm": "Medical Center Pharmacy, Inc.", "address_1": "2401 N Ocoee St", "address_2": "N/A", "postal_code": "37311-3853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Specific prescriptions to patients in TN", "recall_number": "D-1074-2020", "product_description": "C-*Vancomycin Opthal 14 mg drops, 5 mL bottle, Rx only, Medical Center Pharmacy, 2401 Ocoee Street, Cleveland, TN 37311, NDC 67457-0340-01.", "product_quantity": "1 bottle", "reason_for_recall": "Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.", "recall_initiation_date": "20200313", "center_classification_date": "20200401", "termination_date": "20221014", "report_date": "20200408", "code_info": "Lot: 03042020@7 BUD: 03/18/2020"}, {"country": "United States", "city": "Birmingham", "address_1": "6801 Cahaba Valley Rd Ste 116", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "85 mL in Vials", "code_info": "Lot #: 160215-23, BUD: 08/13/16", "center_classification_date": "20160708", "distribution_pattern": "U.S. Nationwide, Japan, and New Zealand.", "state": "AL", "product_description": "TMG 100 MG/ML (PF), 10ML Vials, MEDAUS PHARMACY", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Medaus, Inc.", "recall_number": "D-1248-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "74466", "termination_date": "20170616", "more_code_info": "", "recall_initiation_date": "20160513", "postal_code": "35242-9609", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Birmingham", "state": "AL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "66172", "recalling_firm": "Medaus, Inc.", "address_1": "6801 Cahaba Valley Rd Ste 116", "address_2": "N/A", "postal_code": "35242-9609", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1052-2013", "product_description": "Pyridoxine HCL 100 mg/mL NS (PF), 30 mL, Medaus Pharmacy 1-800-526-9183", "product_quantity": "2970 mL", "reason_for_recall": "Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured.", "recall_initiation_date": "20130823", "center_classification_date": "20130913", "termination_date": "20140716", "report_date": "20130925", "code_info": "LOT # 130531-31, Exp 11/27/2013", "more_code_info": ""}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "43 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015;  03162015@7, 6/14/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Morphine 40 mg/ml + Bupivacaine 16 mg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1600-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0163-2022", "product_description": "TEST CYPIONATE 200MG/ANASTROZOLE 2MG/DUTASTERIDE 0.5MG/ML IN OIL  INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "4 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: T1006032021:45 BUD: 11/30/2021", "more_code_info": ""}, {"status": "Terminated", "city": "St Petersburg", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65125", "recalling_firm": "THE COMPOUNDING SHOP, INC.", "address_1": "4000 Park St N", "address_2": "N/A", "postal_code": "33709-4034", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Florida, California, Minnesota, and Maine", "recall_number": "D-562-2013", "product_description": "Procaine 1% Injectable, 100 mL and 250 mL vials, compounded by The Compounding Shop, St. Petersburg, FL", "product_quantity": "2 vials of 250mL and 26 vials of 100mL", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "recall_initiation_date": "20130502", "center_classification_date": "20130604", "termination_date": "20240930", "report_date": "20130612", "code_info": "All Lots"}, {"status": "Terminated", "city": "Pennsauken", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"brand_name": ["CETACAINE ANESTHETIC"], "generic_name": ["BENZOCAINE, BUTAMBEN, AND TETRACAINE HYDROCHLORIDE"], "manufacturer_name": ["Cetylite Industries, Inc."], "product_ndc": ["10223-0202", "10223-0225", "10223-0226"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["BENZOCAINE", "BUTAMBEN", "TETRACAINE HYDROCHLORIDE"], "rxcui": ["543786", "543789"], "spl_id": ["66344c64-2439-4a34-8eb4-707e707c8ab1"], "spl_set_id": ["89f262a4-a41b-41d7-806b-61b9b89542f0"], "package_ndc": ["10223-0202-2", "10223-0202-4", "10223-0202-5", "10223-0202-6", "10223-0202-7", "10223-0202-8", "10223-0225-1", "10223-0226-1", "10223-0202-3"], "is_original_packager": [true], "nui": ["N0000185508", "N0000175629", "N0000184306", "M0000728"], "pharm_class_epc": ["Standardized Chemical Allergen [EPC]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]"], "pharm_class_cs": ["Allergens [CS]"], "unii": ["5NF5D4OPCI", "U3RSY48JW5", "EFW857872Q"]}, "product_type": "Drugs", "event_id": "66012", "recalling_firm": "Cetylite Industries, Inc.", "address_1": "9051 River Road", "address_2": "N/A", "postal_code": "08110-3203", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-019-2014", "product_description": "Cetacaine Liquid Topical Anesthetic,  Rx Only, a) 14 g bottle (NDC 10223-0202-2); Kit w/14 g (NDC 10223-0202-3); 30 g bottle (NDC 10223-0202-4) Manufactured by Cetylite Industries, Inc., 9051 River Road Pennsauken, NJ 08110       -", "product_quantity": "30 g - 11403 units; 14 g  - 7338 units 14 g kit - 200 units", "reason_for_recall": "Subpotent Drug: Cetacaine Topical Anesthetic Liquid is being recalled because one of the three active ingredients, tetracaine, is below the specification limit  at the 21 month stability test point.", "recall_initiation_date": "20130402", "center_classification_date": "20131126", "termination_date": "20140801", "report_date": "20131204", "code_info": "Lot 470  exp.  04/13, 471 exp. 06/13, 472 exp.  10/13"}, {"country": "United States", "city": "Springerville", "address_1": "105 W Main St", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "2 containers", "code_info": "all lots", "center_classification_date": "20151201", "distribution_pattern": "Nationwide in US: Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah", "state": "AZ", "product_description": "Calcium EDTA 300mg/mL Injection, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Western Drug", "recall_number": "D-0422-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "72520", "termination_date": "20161001", "more_code_info": "", "recall_initiation_date": "20151019", "postal_code": "85938-7203", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Nashville", "state": "TN", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "68455", "recalling_firm": "Nature's Universe", "address_1": "2817 West End ave.", "address_2": "N/A", "postal_code": "37203-1453", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S. Nationwide and Canada", "recall_number": "D-1594-2014", "product_description": "THINOGENICS, WEIGHT LOSS MADE EASY!  DIETARY SUPPLEMENT, 30 CAPSULES, 30 Count Bottles, THINOGENICS LLC, Nashville, TN  37203 USA.", "product_quantity": "Unknown", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: Product contains undeclared sibutramine.", "recall_initiation_date": "20140409", "center_classification_date": "20140918", "termination_date": "20150410", "report_date": "20140924", "code_info": "None Available.  All lots distributed prior to 02/06/2014 are being recalled.", "more_code_info": ""}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0247-2020", "product_description": "S-PYRIDOXINE HCL (B6) 100MG/ML MDV, Rx Only, 30ml glass vial. Red Mountain Compounding Rx.", "product_quantity": "38x30 ml glass vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #:  S03072019DH@10, Exp 9/7/19; S04162019DT@18, Exp 10/16/19; S05162019DH@09, Exp 11/16/19; S05232019DT@11, Exp 11/23/19; s06182019dh@31, Exp 12/18/19; S06242019DH@14, Exp 12/24/19; S07172019DT@08, Exp 1/17/20;  S07232019DH@16, Exp 1/23/20; S06242019DH@14, Exp 12/24/19"}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90512", "recalling_firm": "Nephron Sterile Compounding Center LLC", "address_1": "4500 12th Street Ext", "address_2": "N/A", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1260-2022", "product_description": "Ketamine HCl Injection, USP 30 mg/3 mL (10 mg/mL*) syringes, packaged in 5 x 3 mL Pre-Filled Syringes per carton, 6 x 5 Syringe Carton per case, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-982-33", "product_quantity": "30,745 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220630", "center_classification_date": "20220718", "termination_date": "20240617", "report_date": "20220727", "code_info": "Lots: KH2002A, Exp. 7/5/2022"}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA125469"], "brand_name": ["TRULICITY"], "generic_name": ["DULAGLUTIDE"], "manufacturer_name": ["Eli Lilly and Company"], "product_ndc": ["0002-3182", "0002-1433", "0002-1434", "0002-2236"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["DULAGLUTIDE"], "rxcui": ["1551295", "1551300", "1551304", "1551306", "2395777", "2395779", "2395783", "2395785"], "spl_id": ["2a046089-7cd3-43d3-9f7f-27e3e4b49f0d"], "spl_set_id": ["463050bd-2b1c-40f5-b3c3-0a04bb433309"], "package_ndc": ["0002-1433-01", "0002-1433-80", "0002-1433-61", "0002-1434-01", "0002-1434-80", "0002-1434-61", "0002-2236-01", "0002-2236-80", "0002-2236-61", "0002-3182-01", "0002-3182-80", "0002-3182-61"], "is_original_packager": [true], "nui": ["N0000178480", "M0160181", "N0000020058"], "pharm_class_epc": ["GLP-1 Receptor Agonist [EPC]"], "pharm_class_cs": ["Glucagon-Like Peptide 1 [CS]"], "pharm_class_moa": ["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"], "unii": ["WTT295HSY5"]}, "product_type": "Drugs", "event_id": "88505", "recalling_firm": "Eli Lilly & Company", "address_1": "839 S Delaware St", "address_2": "N/A", "postal_code": "46225-1782", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0773-2021", "product_description": "Trulicity (dulaglutide), 0.75 mg/0.5 mL, 4 Single-Dose Pens per box, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 0002-1433-80", "product_quantity": "119,539 4-packs", "reason_for_recall": "Labeling: Label error on declared strength - autoinjector devices labeled as 0.75 mg / 0.5 mL actually contain 1.5 mg / 0.5 mL of product.", "recall_initiation_date": "20210819", "center_classification_date": "20210826", "termination_date": "20230807", "report_date": "20210901", "code_info": "Lot number: D396436C"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; LEVOTHYROXINE/ LIOTHYRONINE Tablet, 19 mcg/4.5 mcg may be potentially mislabeled as    MAGNESIUM GLUCONATE DIHYDRATE, Tablet, 500 mg (27 mg Elemental Magnesium), NDC 60258017201, Pedigree: AD30197_16, EXP: 5/9/2014.", "address_2": "", "product_quantity": "102 Tablets", "code_info": "LEVOTHYROXINE/ LIOTHYRONINE Tablet, 19 mcg/4.5 mcg has the following code    Pedigree: AD30197_19, EXP: 3/31/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LEVOTHYROXINE/ LIOTHYRONINE Tablet, 19 mcg/4.5 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 42192032901", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-555-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Gibbstown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95854", "recalling_firm": "Keystone Industries", "address_1": "480 S Democrat Rd", "address_2": "", "postal_code": "08027-1239", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA and Canada, Dominican Republic, El Salvador, Honduras, and Qatar.", "recall_number": "D-0144-2025", "product_description": "Pearson Quality, Topical Anesthetic Gel, 20% Benzocaine, For Professional Use Only, Net Contents: 1 oz (30 g), Manufactured for Pearson Dental Supply Inc., Sylmar, CA 91342 USA.", "product_quantity": "", "reason_for_recall": "CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.", "recall_initiation_date": "20241114", "center_classification_date": "20241213", "report_date": "20241225", "code_info": "Lot: BNZ-001646, Exp Date: 11/26/2026, Keystone Item No. 03-30619", "more_code_info": ""}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83908", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to major distributors throughout the United States who may have further distributed the product.", "recall_number": "D-0169-2020", "product_description": "Ranitidine Tablets, USP 150 mg, 190 count bottles (2x95) Tray (Sam's Club) OTC, NDC 150062076  UPC Code 078742089720", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "recall_initiation_date": "20191001", "center_classification_date": "20191105", "report_date": "20191113", "code_info": "Batch Numbers:  All lots within expiry."}, {"status": "Terminated", "city": "Independence", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72796", "recalling_firm": "AGA Gas Inc", "address_1": "6055 Rockside Woods Blvd", "address_2": "N/A", "postal_code": "44131-2301", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was delivered to Ohio", "recall_number": "D-0779-2016", "product_description": "Oxygen, USP, 99.0%, Bulk Cryogenic Liquid, Rx, Airgas Merchant Gases, LLC, Independence, OH --- NDC 33237-001-01", "product_quantity": "1,500 gallons", "reason_for_recall": "cGMP Deviations; trailer may not have met GMP requirements prior to filling", "recall_initiation_date": "20151129", "center_classification_date": "20160318", "termination_date": "20171213", "report_date": "20160330", "code_info": "Lot# 7931-O-V32-5330-5-1062"}, {"status": "Terminated", "city": "Smyrna", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M016"], "brand_name": ["PURE PETROLEUM", "PETROLEUM"], "generic_name": ["WHITE PETROLATUM"], "manufacturer_name": ["Rite Aid", "Kroger Co", "Harris Teeter", "CVS Pharmacy"], "product_ndc": ["11822-3135", "30142-069", "72036-069", "59779-069"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["PETROLATUM"], "rxcui": ["204754"], "spl_id": ["3014c11a-12bd-f4cf-e063-6294a90a4f3e", "2fc412c2-055a-7abe-e063-6394a90ab4f8", "2f761251-19bd-21e9-e063-6294a90a45bf", "2f268446-42d2-0fd6-e063-6294a90ae2c7"], "spl_set_id": ["f67be4cc-9983-4758-93c8-383919ec07ca", "d2095c7b-61ca-40d3-bbf1-04bed4dd789c", "de380df6-cc6e-4b2a-98de-fc08eeb6e8ea", "4dc08832-e610-4e62-a6af-cadaa339e39e"], "package_ndc": ["11822-3135-4", "11822-3135-2", "30142-069-07", "30142-069-27", "30142-069-54", "72036-069-27", "72036-069-54", "59779-069-27", "59779-069-54", "59779-069-18", "59779-069-96"], "is_original_packager": [true], "upc": ["0011822313544", "0072036750501", "011822513494", "041260352751", "072036750518", "050428317020"], "unii": ["4T6H12BN9U"]}, "product_type": "Drugs", "event_id": "94710", "recalling_firm": "Consumer Product Partners, LLC", "address_1": "1 Swan Dr", "address_2": "N/A", "postal_code": "37167-2099", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0560-2024", "product_description": "Petroleum Jelly, White Petrolatum USP, NET WT 13 OZ (368g), sold under the following brands - Rite Aid, with UPC 0-11822-51349-4; Kroger, with UPC 0-41260-35275-1; Harris Teeter, with UPC 0-72036-75051-8; CVS, with UPC 0-50428-31702-0", "product_quantity": "1015 cases", "reason_for_recall": "Labeling: Label Mix up; product labeled as pure white petroleum jelly actually contains petroleum jelly with Lavendar and Chamomile", "recall_initiation_date": "20240528", "center_classification_date": "20240618", "termination_date": "20250821", "report_date": "20240626", "code_info": "Rite Aid - lot # 0607983, expiration date: 07/2026, NDC # 11822-3135-2 Kroger- lot # 0607983, expiration date: 07/2026, NDC# 30142-069-27 Harris Teeter - lot # 0607983, expiration date: 07/2026, NDC# 72036-069-27 CVS- lot # 0607983, expiration date: 07/2026, NDC # 59779-069-27"}, {"country": "United States", "city": "South Lyon", "address_1": "350 S Lafayette St", "reason_for_recall": "Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.", "address_2": "", "product_quantity": "4.4 mL", "code_info": "All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #: 09242013@1", "center_classification_date": "20140110", "distribution_pattern": "Hospitals, clinics, physicians, and patients in the Michigan area only.", "state": "MI", "product_description": "FLUOROURACIL* PF  50 mg/mL INJECTABLE, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI  48178", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Specialty Medicine Compounding Pharmacy", "recall_number": "D-421-2014", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "66566", "termination_date": "20140922", "more_code_info": "", "recall_initiation_date": "20131019", "postal_code": "48178-1814", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0319-2017", "product_description": "TriMix, Alprostadil/Phentolamine/Papaverine 40mcg/2mg/30mg/mL, (1 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "17 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.    Known lot codes (Exp Date): 07112016B (08/22/2016), 09222016H (11/06/2016), 10252016F (12/09/2016), 09232016S (11/06/2016), 09072016E (09/29/2016), 11032016F (12/09/2016)."}, {"status": "Terminated", "city": "Corvallis", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82278", "recalling_firm": "Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy", "address_1": "996 Nw Circle Blvd Ste 105", "address_2": "N/A", "postal_code": "97330-1485", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed in Oregon", "recall_number": "D-1097-2019", "product_description": "PAPAVERINE-PHENTOLAMINE-PGE1 30-1.6 MG-16 MCG/ML* INJECTABLE, (a) 5ml, (b) 10ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .", "product_quantity": "3 prescription 5, 10 ml injection", "reason_for_recall": "Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.", "recall_initiation_date": "20190221", "center_classification_date": "20190409", "termination_date": "20200723", "report_date": "20190417", "code_info": "Lot: 05102018@36,27112018@49, (b) 28112018@54,  distributed between 09-01-2018 to 02-20-2019."}, {"status": "Terminated", "city": "San Luis Obispo", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84284", "recalling_firm": "Integrated Health Concepts Inc. dba Conversio Health", "address_1": "720 Aerovista Pl Ste D", "address_2": "N/A", "postal_code": "93401-8726", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0511-2020", "product_description": "Albuterol 2.5mg / Ipratropium 0.75mg /Budesonide 0.5mg, 3ML Vial, For Inhalation Only, Conversio Health, San Luis Obispo, CA 93401.", "product_quantity": "N/A", "reason_for_recall": "Lack of Processing Controls", "recall_initiation_date": "20191112", "center_classification_date": "20191119", "termination_date": "20200528", "report_date": "20191127", "code_info": "All Lots"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "6 units", "code_info": "Rx #'s:   0362307    0404196    0395753    0395753    0388923    0364468", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "PHENTOLAMINE 10MG/ML INJECTABLE\t6 ML;  \t  PHENTOLAMINE 1MG/ML INJECTABLE\t2 ML  \t5 ML;  PHENTOLAMINE 5MG/ML INJECTABLE\t20 ML  \t50 ML  (5 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1597-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Palm Harbor", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89808", "recalling_firm": "Drug Depot, Inc., dba APS Pharmacy", "address_1": "34911 Us Highway 19 N Ste 600", "address_2": "N/A", "postal_code": "34684-1921", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA including Puerto Rico.", "recall_number": "D-0735-2022", "product_description": "TESTOSTERONE CYPIONATE  *GS* (2 mL) 80 MG/ML Injectable, Packaged in a multi dose 10ML vial, Formula ID 127492, APS Pharmacy", "product_quantity": "17 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20220323", "center_classification_date": "20220329", "termination_date": "20231005", "report_date": "20220406", "code_info": "Lot: 746269 BUD: 6/27/2022"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73925", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0061-2017", "product_description": "lidocaine HCl, 1%, 30 mg per 3 mL, 3 mL Total Volume in a syringe, Rx only, PharMEDium, Product code 2R3104.", "product_quantity": "500 syringes", "reason_for_recall": "Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.", "recall_initiation_date": "20150717", "center_classification_date": "20161012", "termination_date": "20170623", "report_date": "20161019", "code_info": "Lot Numbers: 15117146M, 15121045M, 15125052M, 15131008M, 15133051M, 15140028M, 15149043M, 151890293M, Exp between 07/15/15-10/12/15"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-027-2014", "product_description": "Acetylcystein 20% 90ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "1 unit", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1080-2022", "product_description": "Revonto (dantrolene sodium for injection), 20 mg/vial, 6-count box, Rx only, MFG: US WorldMeds, Inc., NDC 27505-003-67", "product_quantity": "16 cartons/6 vials each", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0139-2016", "product_description": "TESTOSTERONE, Pellet, 80 mg,  Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "13 pellets", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t10222014@22, t10032014@21, t09092014@15, t09032014@11, t06292015@18, t06022015@6, t02132015@16, t02122015@1, t01092015@5."}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "144 pellets", "code_info": "All lots distributed between November 2014 and May 2015;  11212014@13, 5/20/2015; 12182014@35, 6/16/2015; 02202015@1, 8/19/2015; 03022015@48, 8/29/2015; 03172015@33, 9/13/2015; 04232015@24, 10/20/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Estradiol 6 mg, Sterile Pellet, The Compounding Pharmacy of America, Inc., Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1475-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA020161"], "brand_name": ["POTASSIUM CHLORIDE"], "generic_name": ["POTASSIUM CHLORIDE"], "manufacturer_name": ["ICU Medical Inc."], "product_ndc": ["0990-7074", "0990-7075", "0990-7077"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["POTASSIUM CHLORIDE"], "rxcui": ["312507", "1860239", "1860241", "1860463", "1860466"], "spl_id": ["88bcbbe4-9ebf-4491-874a-c4c4c7f1f90d"], "spl_set_id": ["eb56a807-ea94-4edb-9811-a04b19568468"], "package_ndc": ["0990-7074-26", "0990-7075-14", "0990-7075-26", "0990-7077-14", "0990-7077-26", "0030990707"], "is_original_packager": [true], "unii": ["660YQ98I10"]}, "product_type": "Drugs", "event_id": "96250", "recalling_firm": "ICU Medical, Inc.", "address_1": "600 N Field Dr", "address_2": "", "postal_code": "60045-4835", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0268-2025", "product_description": "POTASSIUM CHLORIDE Inj., 10 mEq total in 100 mL, 100 mEq/L flexible container, Rx Only, ICU Medical, Inc., Lake Forest, Illinois, 60045, USA, NDC# 0990-7074-26; Bar Code (01)00309907074269", "product_quantity": "unknown", "reason_for_recall": "Labeling: Label Error on Declared Strength. Overwrap labeled as Potassium Chloride Inj 10 mEq may contain flexible containers of Potassium Chloride Inj 20 mEq", "recall_initiation_date": "20250213", "center_classification_date": "20250310", "report_date": "20250319", "code_info": "Lot 1023172, Exp Date: 31 January 2026", "more_code_info": ""}, {"status": "Terminated", "city": "Westlake Village", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72402", "recalling_firm": "Chen Shwezin, Inc. dba Park Compounding Pharmacy", "address_1": "280 N Westlake Blvd Ste 100", "address_2": "N/A", "postal_code": "91362-7014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "CA", "recall_number": "D-0159-2016", "product_description": "CAFFEINE + SODIUM BENZOATE 500MG/ML, 35 mL vial, Rx only, Park Compounding Pharmacy 280 N. Westlake Blvd., Ste. 100 Westlake Village, CA 91362, (805) 497-8258", "product_quantity": "2 vials", "reason_for_recall": "Lack of Assurance of Sterility: all sterile compounded products within expiry", "recall_initiation_date": "20151006", "center_classification_date": "20151028", "termination_date": "20151127", "report_date": "20151104", "code_info": "Lot# 08062015@27, Exp, 11/4/15"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0289-2020", "product_description": "S-TEST CYP/PROP/DECA-NAN 250MG/ML (80/10/10)   IN SESAME OIL, Rx only, Rx Only, 10ml glass vial. Red Mountain Compounding Rx.", "product_quantity": "1x10 ml glass vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #: S06242019DH@06, Exp 9/24/2019;"}, {"status": "Completed", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90204", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands", "recall_number": "D-0919-2022", "product_description": "AT-6 Papaverine 40 mg/mL Phentolamine 4 mg/mL Atropine 0.3 mg/mL, Multi-Dose 10 mL vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835 NDC 73198-0040-10", "product_quantity": "528 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20220509", "center_classification_date": "20220525", "report_date": "20220601", "code_info": "Lot: K24409 BUD: 11/9/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75164", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "MS", "recall_number": "D-1549-2016", "product_description": "DMSO 50% with Lidocaine 0.5%, 50ml SDV, Sterile, Rx, Vital Care Compounder, Hattiesburg, MS", "product_quantity": "6 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160726", "center_classification_date": "20160927", "termination_date": "20161118", "report_date": "20161005", "code_info": "Lot # 389321, Use by 3/10/17"}, {"status": "Terminated", "city": "Augusta", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64661", "recalling_firm": "Clinical Specialties Compounding Pharmacy", "address_1": "318 Baston Rd", "address_2": "N/A", "postal_code": "30907", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "FL, GA and SC.", "recall_number": "D-650-2013", "product_description": "Latanoprost 0.025% eye drop, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907", "product_quantity": "70ml total", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "recall_initiation_date": "20130320", "center_classification_date": "20130703", "termination_date": "20170222", "report_date": "20130710", "code_info": "Lot number CABDAFAD:09, Exp date: 5/4/2013"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: CILOSTAZOL, Tablet, 100 mg may have potentially been mislabeled as the following drug:  TRIAMTERENE/ HYDROCHLOROTHIAZIDE, Tablet, 37.5 mg/25 mg, NDC 00591042401, Pedigree: W002900, EXP: 6/10/2014.", "address_2": "", "product_quantity": "63 Tablets", "code_info": "CILOSTAZOL, Tablet, 100 mg has the following codes:   Pedigree: W002931, EXP: 6/10/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "CILOSTAZOL, Tablet, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00185022360.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-881-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA018016"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-0043", "0338-0049"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1807551", "1807552", "1807627", "1807630", "1807631", "1807632", "1807633", "1807634", "1807639"], "spl_id": ["6ab23768-efd2-4ff1-b336-0dda08dc56e1"], "spl_set_id": ["f55bd888-5e01-474d-871b-24654c070178"], "package_ndc": ["0338-0049-01", "0338-0049-02", "0338-0049-03", "0338-0049-04", "0338-0049-10", "0338-0049-41", "0338-0049-11", "0338-0049-31", "0338-0049-48", "0338-0049-18", "0338-0049-38", "0338-0043-03", "0338-0043-04"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "67092", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "1 Baxter Pkwy", "address_2": "", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Puerto Rico, Singapore, Saudi Arabia and United Arab Emirates.", "recall_number": "D-1163-2014", "product_description": "0.9% Sodium Chloride Injection, USP, packaged in a) 50 mL Single dose VIAFLEX plastic containers (Product code 2B1308, NDC 0338-0049-31) and b)  100 mL Single dose VIAFLEX plastic containers (Product code 2B1302, NDC 0338-0049-18) and (Product code 2B1309, NDC 0338-0049-38), Rx only, Baxter Healthcare Corporation, Deerfield, IL  60015 USA.", "product_quantity": "716,544 containers", "reason_for_recall": "Presence of Particulate Matter: Baxter is issuing a voluntary recall for these IV solutions due to particulate matter found in the solution identified as polyester and cotton fibers, adhesive-like mixture, polyacetal particles, thermally degraded PVC, black polypropylene and human hair embedded in the plastic bag", "recall_initiation_date": "20131121", "center_classification_date": "20140314", "termination_date": "20160921", "report_date": "20140326", "code_info": "Lot #: a) P297283, Exp 08/14; b) P292326, Exp 04/14; P293993, Exp 05/14; and P293514, Exp 04/14", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079019"], "brand_name": ["ATOMOXETINE"], "generic_name": ["ATOMOXETINE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-265", "68462-266", "68462-267", "68462-268", "68462-269", "68462-270", "68462-271"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOMOXETINE HYDROCHLORIDE"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_id": ["84dc1413-a85b-41f6-a3e3-6e76c01f6803"], "spl_set_id": ["0ab8d905-e890-4e91-a730-3e5d12f5c23f"], "package_ndc": ["68462-265-30", "68462-265-23", "68462-266-30", "68462-266-23", "68462-267-30", "68462-267-23", "68462-268-30", "68462-268-23", "68462-269-30", "68462-269-23", "68462-270-30", "68462-270-23", "68462-271-30", "68462-271-51"], "is_original_packager": [true], "upc": ["0368462270301"], "unii": ["57WVB6I2W0"]}, "product_type": "Drugs", "event_id": "96194", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0232-2025", "product_description": "Atomoxetine Capsules, USP, 18 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-266-30.", "product_quantity": "56,208 bottles", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.", "recall_initiation_date": "20250129", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot Numbers: 19233756, Exp.: 8/2025; 19235111, Exp.: 11/2025; 19242167, Exp.: 5/2026; 19242180, Exp.: 5/2026."}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA204022"], "brand_name": ["ROPINIROLE"], "generic_name": ["ROPINIROLE"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-232", "16729-233", "16729-234", "16729-235", "16729-236", "16729-237", "16729-238"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ROPINIROLE HYDROCHLORIDE"], "rxcui": ["283858", "312845", "312846", "312847", "312849", "314208", "562704"], "spl_id": ["23980eef-2eb5-2b74-e063-6394a90a68ac"], "spl_set_id": ["4a2a5b63-5b14-6975-e054-00144ff8d46c"], "package_ndc": ["16729-232-01", "16729-233-01", "16729-234-01", "16729-235-01", "16729-236-01", "16729-237-01", "16729-238-01"], "is_original_packager": [true], "unii": ["D7ZD41RZI9"], "upc": ["316729236010"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0429-2023", "product_description": "rOPINIRole Tablets USP 3 mg*, 100-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213 INDIA, NDC 16729-236-01, UPC 3 16729 23601 0", "product_quantity": "14,928 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: P2105099, P2105098, Exp. Date 7/31/2023, P2106507, P2106508, P2106510, P2106509, Exp. Date 9/30/2023, P2202750, Exp. Date 4/30/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77780", "recalling_firm": "Cantrell Drug Company", "address_1": "7321 Cantrell Rd", "address_2": "N/A", "postal_code": "72207-4144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the US", "recall_number": "D-1062-2017", "product_description": "Ephedrine Sulfate in 0.9% Sodium Chloride 5 mL, 25 mg/5 mL (5 mg/mL) Single-Dose Syringe, Rx Only, Cantrell Drug Company 7321 Cantrell Rd Little Rock, AR 72207 877-666-5222, NDC 52533-019-15", "product_quantity": "25529 syringes", "reason_for_recall": "Lack of Sterility Assurance.", "recall_initiation_date": "20170714", "center_classification_date": "20170809", "termination_date": "20200916", "report_date": "20170816", "code_info": "Lot #: 9910, 9928, BUD: 7/28/2017; 9962, 9993, BUD: 8/4/2017; 10333, 10481, 10538, BUD: 9/23/2017"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82615", "recalling_firm": "Customceutical Compounding", "address_1": "4611 E Shea Blvd Bldg 3 Ste 180", "address_2": "N/A", "postal_code": "85028-4258", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-1255-2019", "product_description": "Glutathione 200mg/mL inj. a) 10 ML and b) 12 ML MULTIDOSE VIAL MDV Compounded. Customceutical Compounding 4611 E. Shea Blvd. Bldg 3 180, Phoenix, AZ 85028 Ph. 480 516 0272", "product_quantity": "4 vials", "reason_for_recall": "Lack of assurance of sterility for injectables and solutions intended to be sterile.", "recall_initiation_date": "20190408", "center_classification_date": "20190430", "termination_date": "20230519", "report_date": "20190508", "code_info": "Lot #: 02132019@25, Exp 5/14/19"}, {"status": "Terminated", "city": "Longview", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "88291", "recalling_firm": "Med Shop Total Care Inc.", "address_1": "470 E Loop 281", "address_2": "N/A", "postal_code": "75605-7939", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Texas and Puerto Rico", "recall_number": "D-0710-2021", "product_description": "MORPHINE-BUPIVACAINE PF INJECTABLE 21 mL, 22 mL, 23 mL, 41 mL and 43 mL syringes in various strengths: a) 20MG/ML-40MG/ML, b) 15MG-30MG/ML, c) 5MG/ML-20MG/ML, d) 2MG-30MG/ML, e) 20MG-5MG/ML, f) 15MG-5MG/ML, g) 5MG-2MG/ML, h) 5MG-11MG/ML, i) 20MG-6MG/ML, j) 10MG-10MG/ML, k) 6MG-4.8MG/ML, l) 30MG-10MG/ML, m) 5MG-4MG/ML, n) 10MG/ML-20MG/ML, o) 40MG-5MG/ML, p) 20MG-20MG/ML, q) 30MG-20MG/ML, Rx only, Med Shop Total Care 470 East Loop 281 Longview, TX 75605", "product_quantity": "466 mL", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20201005", "center_classification_date": "20210809", "termination_date": "20230817", "report_date": "20210818", "code_info": "Lot #: a) 09282020@62, BUD 10/27/2020, 09302020@25, BUD 10/29/2020, b) 09292020@56, c) 09292020@58, d)09292020@60, e) 09292020@66, 09292020@73, f) 09292020@70, g) 09292020@71, h) 09292020@77, i) 09302020@20 j) 09302020@33, k) 09302020@48, l) 09302020@61, m) 09302020@66, n) 09302020@70,  o) 09302020@26, BUD 10/29/2020, p) 10012020@8, q) 10022020@20,  BUD 10/30/2020"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "35 ML", "code_info": "All lots distributed between November 2014 and May 2015;  05042015@47, 8/2/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Copper (Cupric)Sulfate 2 mg/ml Injectable, Multi-Dose Vial, Sterile, Refrigerate, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1456-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Qinhuangdao", "state": "N/A", "country": "China", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76890", "recalling_firm": "Qinhuangdao Zizhu Pharmaceutical, Co.", "address_1": "No 10, Longhai Road", "address_2": "Economic &amp; Technological Development Zon", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product distributed to NY, TX, SC, CO, MN and NJ", "recall_number": "D-0657-2017", "product_description": "Estrone Micronized, USP, Bulk, Rx only, For Prescription Compounding, Manufactured by Qinhuangdao Zizhu Pharmaceutical Co., Ltd., Qinhuangdao 066004, China (NDC 44132-003-04) (NDC 44132-003-02)(NDC 44132-003-06)", "product_quantity": "N/A", "reason_for_recall": "cGMP Deviations; lack of quality assurance.", "recall_initiation_date": "20170324", "center_classification_date": "20170411", "termination_date": "20180703", "report_date": "20170419", "code_info": "Batch 82801505001 to 82801606001, exp 5/4/2017 through 5/19/2018", "more_code_info": ""}, {"country": "United States", "city": "Lake Forest", "address_1": "150 N Field Dr Ste 350", "reason_for_recall": "Subpotent Drug", "address_2": "", "product_quantity": "180 syringes", "code_info": "Lot #: 15002077M, Exp 04-02-2015", "center_classification_date": "20160218", "distribution_pattern": "Nine specific hospital pharmacies in VA, IA, WI, CO, CA, PA, and OK.", "state": "IL", "product_description": "fentaNYL Citrate, Preservative Free, 5 mcg per mL In 0.9% Sodium Chloride, 1 mL Total Volume For IV Use, packaged in a 3 mL syringe, code 2R3479, PharMEDium.", "report_date": "20160224", "classification": "Class I", "openfda": {}, "recalling_firm": "Pharmedium Services, LLC", "recall_number": "D-723-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "72380", "termination_date": "20160222", "more_code_info": "", "recall_initiation_date": "20150113", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Nicholasville", "state": "KY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89909", "recalling_firm": "TMC Acquisition LLC dba Tailor Made Compounding", "address_1": "200 Moore Dr", "address_2": "", "postal_code": "40356-8512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-1224-2022", "product_description": "Semaglutide/Cyanocobalamin 2mg/0.4mg/ml, 1mL-vial,  Refrigerate, Tailor Made Compounding", "product_quantity": "5,842 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220307", "center_classification_date": "20220714", "report_date": "20220720", "code_info": "Batch#: 12032123A2, Exp 3/3/2022; 12102101A2, Exp 3/10/2022; 12202105A2, Exp 3/20/2022; 12292106A2, Exp 3/29/2022; 01062218B, Exp 4/6/2022; 01192228A2, Exp 4/19/2022; 01312214A2, Exp 5/1/2022; 02012211A1, Exp 5/2/2022; 02182201A1, 02182203A1, Exp 5/19/2022; 02242205A1, 02242206A1, Exp 5/25/2022; 03072209A1, Exp 6/5/2022; 03092203A1, 03092206A1, Exp 6/7/2022.", "more_code_info": ""}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA077908"], "brand_name": ["PROPOFOL"], "generic_name": ["PROPOFOL"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-4699", "0409-6010"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["PROPOFOL"], "rxcui": ["1808217", "1808222", "1808224"], "spl_id": ["d55c0318-811d-4624-aa0c-456182f7b019"], "spl_set_id": ["28d7ba00-f824-4e55-139a-03f509c099db"], "package_ndc": ["0409-4699-50", "0409-4699-30", "0409-4699-53", "0409-4699-33", "0409-4699-54", "0409-4699-24", "0409-6010-02", "0409-6010-25"], "is_original_packager": [true], "nui": ["N0000175975", "N0000175681"], "pharm_class_pe": ["General Anesthesia [PE]"], "pharm_class_epc": ["General Anesthetic [EPC]"], "unii": ["YI7VU623SF"]}, "product_type": "Drugs", "event_id": "90581", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "USA Nationwide", "recall_number": "D-1301-2022", "product_description": "Propofol Injectable Emulsion, 1 g/100 mL (10 mg/mL), packaged in 100 mL per glass fliptop vial (NDC 0409-4699-54) further packaged in a tray of 10 vials (NDC Carton: 0409-4699-24), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA", "product_quantity": "54,000 vials", "reason_for_recall": "Presence of particulate matter: particulate identified as a beetle.", "recall_initiation_date": "20220713", "center_classification_date": "20220803", "termination_date": "20240513", "report_date": "20220803", "code_info": "Lot #: DX9067, Exp 5/1/2023", "more_code_info": ""}, {"status": "Terminated", "city": "San Jose", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "66103", "recalling_firm": "Leiter's Pharmacy", "address_1": "1700 Park Ave", "address_2": "N/A", "postal_code": "95126-2033", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-1039-2013", "product_description": "Hyaluron (hyaluronidase) 150 units/mL Preserved Solution, 1 mL, Multi Dose Vial, Compounded by Leiter's Compounding Pharmacy, 1700 Park Ave., # 30, San Jose, CA 95126", "product_quantity": "810 vials", "reason_for_recall": "Lack of Assurance of Sterility: Leiter Pharmacy is recalling due bacterial contamination found after investigation at contract testing laboratory discovered that OOS results were reported to customers as passing.  Hence the sterility of these products cannot be assured.", "recall_initiation_date": "20130826", "center_classification_date": "20130913", "termination_date": "20140814", "report_date": "20130925", "code_info": "Lot #:  06122013@9; Exp 9/10/13", "more_code_info": ""}, {"country": "United States", "city": "Albuquerque", "address_1": "1339 San Mateo Blvd Se", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared dexamethasone and cyproheptadine which are FDA approved drugs making this product an unapproved drug.", "address_2": "Apt 2", "product_quantity": "38 bottles", "code_info": "All lots", "center_classification_date": "20141230", "distribution_pattern": "Nationwide", "state": "NM", "product_description": "GINSENG KIANPI PIL, 60 capsules, PRODUCT OF KWEILIN DRUG MANUFACTORY", "report_date": "20150107", "classification": "Class II", "openfda": {}, "recalling_firm": "One and Zen", "recall_number": "D-0329-2015", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "69836", "termination_date": "20150323", "recall_initiation_date": "20141120", "postal_code": "87108-4697", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0207-2015", "product_description": "MITOMYCIN, 0.3mg/mL, injectable, 1 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070", "product_quantity": "8 mL", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140913@4, discard date: 10/28/2014"}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA071858"], "brand_name": ["CLORAZEPATE DIPOTASSIUM"], "generic_name": ["CLORAZEPATE DIPOTASSIUM"], "manufacturer_name": ["Aurolife Pharma LLC"], "product_ndc": ["13107-282", "13107-283", "13107-284"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CLORAZEPATE DIPOTASSIUM"], "rxcui": ["197464", "197465", "197466"], "spl_id": ["69451c35-dd9a-4690-8d5e-4dcfa8837620"], "spl_set_id": ["69451c35-dd9a-4690-8d5e-4dcfa8837620"], "package_ndc": ["13107-282-01", "13107-282-05", "13107-283-01", "13107-283-05", "13107-284-01"], "is_original_packager": [true], "unii": ["63FN7G03XY"]}, "product_type": "Drugs", "event_id": "94500", "recalling_firm": "Aurobindo Pharma USA Inc.", "address_1": "279 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0491-2024", "product_description": "Clorazepate Dipotassium Tablets, USP, 3.75 mg, a) 100 tablets per bottle, NDC 13107-282-01 b) 500 tablets per bottle, NDC 13107-282-05, Rx Only, Distributed by Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India.", "product_quantity": "6696 bottles", "reason_for_recall": "Discoloration: Dotted and yellow spots on tablets", "recall_initiation_date": "20240424", "center_classification_date": "20240508", "report_date": "20240515", "code_info": "Lot #s: a) CZA124001B, CZA124002B, CZA124003B, Exp. 12/31/2025; b) CZA124001A, CZA124003A, Exp. 12/31/2025."}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84213", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "N/A", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed Nationwide throughout the United States, Canada and Saudi Arabia", "recall_number": "D-0491-2020", "product_description": "Calcarea Fluorica 6X Tablets, 300-count bottle, 30g, Manufactured in India exclusively for: Washington Homeopathic Products, Inc., 260 JR Hawvermale Way, Berkeley Springs, WV  25411, barcode 7 40640 64188 0.", "product_quantity": "489 bottles", "reason_for_recall": "CGMP Deviations: products were not manufactured under current good manufacturing practices.", "recall_initiation_date": "20191108", "center_classification_date": "20191118", "termination_date": "20230104", "report_date": "20191127", "code_info": "Lot #: BR18C279"}]